Care home staff and residents walk 7000 miles for cancer
Cillian Hennessey, chief executive of Meallmore, said: "I'm so incredibly proud of everyone who took part in this amazing challenge.
"This result really showcases the remarkable enthusiasm and spirit of our teams, as well as of our residents and local communities who joined in the fun.
"There were some wonderful displays of camaraderie, determination, and teamwork over the week, which was a joy to see."
Read more: STV presenter 'brings the sunshine' to officially open Glasgow care home
A total of 313 staff members from Meallmore's 27 care homes across Scotland took part in the event, walking an impressive 7154 miles - well exceeding their original goal of 1000 miles.
The challenge, I Would Walk 1000 Meallmore Miles, was initially intended as a wellbeing event to encourage exercise and team spirit.
However, the response far surpassed expectations, and even residents and families also participated alongside staff, with ages ranging from six to 102.
Participants contributed to the total through walking, running, and even canoeing, with some residents taking part in wheelchairs and trishaws.
Special events were organised across the care homes to encourage participation, including themed days, group walks, and celebrations.
In the end, the fundraising efforts culminated in a total of £7000 for Cancer Research UK, a charity chosen by both staff and residents in recognition of its important work.
Read more: University of Strathclyde spin-out secures £750k for cancer technology
Cillian said: "While it's typical Meallmore culture to go above and beyond, the teams and residents have really excelled themselves, smashing the target and raising a great amount of money for an important charity.
"A huge well done to all those who racked up these miles in any way possible, as well as a special mention to everyone who supported and donated.
"7,000 miles is an enormous distance, and it really is something that we can all be proud of.
"The bar has been raised for next year."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Record
a few seconds ago
- Daily Record
Scots scientists make breast cancer discovery that could stop disease spreading
The discovery could offer patients a vital new window for cancer intervention. A team of Scots scientists have made a groundbreaking new discovery which could help stop the spread of breast cancer - one of the leading causes of death from the disease. Under the research, conducted by experts at the Cancer Research UK Scotland Institute and the University of Glasgow, patients could be offered a vital new window for intervention. The study focused on how breast cancer changes the immune system so it can't tackle cancer cells as they begin to spread. The researchers found that cancer changes the metabolism (the way cells make and use energy) of specific immune cells resulting in them releasing a prominent metabolite called uracil. Uracil is a molecule key to essential processes in the body which was found to help distant organs build a 'scaffold' to grow secondary tumours elsewhere in the body. By blocking an enzyme called uridine phosphorylase-1 (UPP1), which produces uracil, the scientists were able to stop this scaffold forming in mice and restore the ability of the immune system to kill secondary cancer cells to prevent metastasis. It opens the door to new potentially powerful new tools to tackle cancer - detecting uracil in the blood could help spot early signs of cancer spread then blocking UPP1 with drugs could stop the spread before it starts. The study was conducted in the labs of Professor Jim Norman and Professor Karen Blyth at the Cancer Research UK Scotland Institute and the University of Glasgow. Study lead Dr Cassie Clarke, of the Cancer Research UK Scotland Institute and University of Glasgow, said: "This study represents a major shift in how we think about preventing the spread of breast cancer. By targeting these metabolic changes as early as possible we could stop the cancer progressing and save lives.' Every year, around 56,800 people are diagnosed with breast cancer in United Kingdom. Around 11,300 people sadly lose their lives to the disease. Thanks to research, breast cancer has become a far more treatable disease, but once it spreads to other areas within the body it becomes harder to control effectively. Understanding how and why breast cancer spreads is key to preventing the disease becoming unmanageable with current therapies. Cancer Research UK's Director of Research, Dr Catherine Elliott, said: ' Discoveries in cancer research have made huge strides in making breast cancer a far more treatable disease than ever before. 'However, metastasis - when cancer spreads - is a major factor in breast cancer becoming harder to treat especially if the cancer returns months or even many years later. 'This discovery gives us new hope for detecting and stopping metastasis early and ensuring people have many more years with their families and loved ones.' Simon Vincent, chief scientific officer at Breast Cancer Now, said: 'This is an exciting piece of joint research that expands our understanding of how secondary breast cancer develops. 'The researchers discovered that high levels of a protein called UPP1 may make some cancers, including breast cancer, more likely to spread to other parts of the body, where the disease becomes incurable. 'In mice, targeting the UPP1 protein before secondary breast cancer developed led to fewer secondary breast tumours and a boosted immune response in the lungs. 'Now we need more research to see if this new insight can be turned into new drugs that stop secondary breast cancer, and potentially other secondary cancers, in their tracks. With around 61,000 people living with secondary breast cancer in the UK, research like this is vital."
Daily Mirror
7 hours ago
- Daily Mirror
Woman, 48, dies suddenly in Alicante airport on her way back from 'best holiday'
Angela McTier, 48, from Lanarkshire, was heading to Alicante airport in a taxi to fly home after a break in La Mata in south east Spain when she was suddenly taken ill A Scottish grandmother tragically passed away at a Spanish airport whilst returning from her holiday. Angela McTier, from Blantyre in Lanarkshire, was travelling to Alicante airport in a taxi when she suffered a burst varicose vein, resulting in severe blood loss. The 48 year old made it to the airport but collapsed in the departure lounge. Sadly, despite emergency treatment, she passed away at the scene on Tuesday July 22. Her daughter, Michelle Hilston, told STV that her mum had been working to get healthier so she could see her granddaughters grow up. The 24 year old said: "My mum watched the grandkids at least two nights every week and always looked forward to them coming over. I'm heartbroken for my two girls who have just lost that special relationship with her. If there's one thing my mum loved, it was going on holiday, she thrived over there and this particular holiday to La Mata she just kept saying how amazing it was, it was her best holiday and she'd felt so well and couldn't wait to bring the grandkids over. "She was due to go away with me and my two toddlers next month as well." Michelle disclosed that her mum provided crucial help when she was studying for a midwifery degree. She sent her mum a video of her 11-month-old granddaughter taking her first steps, reports the Daily Record. Michelle added: "She helped me out so much to pursue my dream degree after having my kids and always made sure I had all the childcare and financial support I needed. Her holidays were a special thing for her, she went multiple times a year, and it was one of the things she loved doing the most. "But the thing she loved the most was her granddaughters and would ask for pictures of them multiple times a day. The day she died, I had sent her a video of my 11-month-old finally walking, and she was in tears over the video, phoning everyone to tell them, and I'm glad that's the last video she saw of the kids." A Foreign, Commonwealth & Development Office spokesperson said: "We are supporting the family of a British woman who died in Spain." A GoFundMe page has been set up to assist with the expenses of bringing Angela home and covering her funeral costs. You can donate to the fundriser by clicking here.
Times
12 hours ago
- Times
Scientists' discovery could stop breast cancer spreading
Scottish scientists have made a discovery that could help stop breast cancer spreading to other parts of the body. Experts at Cancer Research UK Scotland Institute and the University of Glasgow have found there are key metabolic changes that take place before tumours grow elsewhere. Their work is being hailed as a significant breakthrough because it is often cancer moving from the breast that kills patients. • How I told my sons that I had a rare form of breast cancer Researchers writing in the journal EMBO Reports said identifying the metabolic changes offered a vital window to intervene. Detecting these changes early could allow therapies to stop cancer cells moving around the body and forming tumours elsewhere. Dr Cassie Clarke, lead researcher, said: 'This study represents a major shift in how we think about preventing the spread of breast cancer. By targeting these metabolic changes as early as possible we could stop the cancer progressing and save lives.' About 56,800 people are diagnosed with breast cancer in the United Kingdom each year and 11,300 people lose their lives to the disease. Dr Catherine Elliott, Cancer Research UK's director of research, said: 'Discoveries in cancer research have made huge strides in making breast cancer a far more treatable disease than ever before. • Why the way we diagnose, label and treat cancer is changing 'However, metastasis — when cancer spreads — is a major factor in breast cancer becoming harder to treat, especially if the cancer returns months or even many years later. 'This discovery gives us new hope for detecting and stopping metastasis early and ensuring people have many more years with their families and loved ones.' The study focused on how breast cancer changes the immune system so it cannot tackle cancer cells as they begin their spread. The researchers found that cancer changes the metabolism — the way cells make and use energy — of specific immune cells, resulting in them releasing a prominent metabolite called uracil. Uracil is a molecule key to essential processes in the body which was found to help distant organs build a 'scaffold' to grow secondary tumours elsewhere in the body. By blocking an enzyme called uridine phosphorylase-1 (UPP1), which produces uracil, the scientists were able to stop this scaffold forming in mice and restore the ability of the immune system to kill secondary cancer cells to prevent metastasis. This opens the door to potentially powerful new tools to tackle cancer. Detecting uracil in the blood could help spot early signs of cancer spread, while blocking UPP1 with drugs could stop the spread before it starts. • The Times View: It is time to be optimistic about cancer The research was funded by Cancer Research UK, the Wellcome Trust, the Medical Research Council, Breast Cancer Now and Pancreatic Cancer UK. Simon Vincent, chief scientific officer at Breast Cancer Now, said: 'The researchers discovered that high levels of a protein called UPP1 may make some cancers, including breast cancer, more likely to spread to other parts of the body, where the disease becomes incurable. 'In mice, targeting the UPP1 protein before secondary breast cancer developed led to fewer secondary breast tumours and a boosted immune response in the lungs. 'Now we need more research to see if this new insight can be turned into new drugs that stop secondary breast cancer, and potentially other secondary cancers, in their tracks. With around 61,000 people living with secondary breast cancer in the UK, research like this is vital.' The team are further investigating exactly how UPP1 changes the behaviour of immune cells, exploring the role of immune cell metabolism in early breast cancer initiation, and testing the ability of drugs that block immune cell metabolism to prevent cancer occurring.
